12:00 AM
 | 
Mar 05, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Imvanex regulatory update

Bavarian submitted an MAA to EMA for its Imvanex smallpox vaccine. The company expects a decision on the vaccine next year. The third-generation modified vaccinia Ankara (MVA)...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >